US5463083A
(en)
*
|
1992-07-13 |
1995-10-31 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
US5434151A
(en)
*
|
1992-08-24 |
1995-07-18 |
Cytomed, Inc. |
Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
|
PT650485E
(en)
|
1992-07-13 |
2001-03-30 |
Millennium Pharm Inc |
2,5-DIARIL-TETRA-HYDRO-THIOPHENES -FURANES AND ANALOGS FOR THE TREATMENT OF INFLAMMATORY AND IMMUNE DISORDERS
|
US6201016B1
(en)
|
1994-06-27 |
2001-03-13 |
Cytomed Incorporated |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
US5703093A
(en)
*
|
1995-05-31 |
1997-12-30 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
US5792776A
(en)
*
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
US5750565A
(en)
*
|
1995-05-25 |
1998-05-12 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
DE19605766A1
(en)
*
|
1996-02-16 |
1997-08-21 |
Basf Ag |
Substituted 2-phenylpyridines
|
US6747027B1
(en)
|
1996-07-22 |
2004-06-08 |
Pharmacia Corporation |
Thiol sulfonamide metalloprotease inhibitors
|
ATE233552T1
(en)
*
|
1996-07-22 |
2003-03-15 |
Monsanto Co |
THIOL-SULFONES AS METALLOPROTEINASE INHIBITORS
|
DE19719621A1
(en)
*
|
1997-05-09 |
1998-11-12 |
Hoechst Ag |
Sulfonylaminocarboxylic acids
|
US6800646B1
(en)
|
1999-02-08 |
2004-10-05 |
Pharmacia Corporation |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
BR0112969A
(en)
|
2000-08-04 |
2004-06-22 |
Dmi Biosciences Inc |
Method of using diketopiperazines and compositions containing them
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
AU2003221786A1
(en)
|
2002-04-25 |
2003-11-10 |
Pharmacia Corporation |
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
CA2500652A1
(en)
|
2002-10-02 |
2004-04-15 |
Dmi Biosciences, Inc. |
Diagnosis and monitoring of diseases
|
PL2537524T3
(en)
|
2003-05-15 |
2017-01-31 |
Ampio Pharmaceuticals, Inc. |
Treatment of T-cell mediated diseases
|
BRPI0609879A2
(en)
|
2005-04-28 |
2010-05-11 |
Pfizer Ltd |
amino acid derivatives
|
EP2446887A3
(en)
|
2005-07-12 |
2012-08-15 |
DMI Biosciences, Inc. |
Use of danazol for the treatment of Alzheimer's disease
|
JP5856843B2
(en)
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ,インコーポレイテッド |
Pharmaceutical composition using diketopiperazine
|
PL2554171T3
(en)
|
2009-06-22 |
2015-03-31 |
Ampio Pharmaceuticals Inc |
Method for treatment of diseases
|
JP2013537195A
(en)
|
2010-09-07 |
2013-09-30 |
ディエムアイ アクイジション コーポレイション |
Disease treatment
|
WO2013055749A1
(en)
|
2011-10-10 |
2013-04-18 |
Ampio Pharmaceuticals, Inc. |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
ES2795803T3
(en)
|
2011-10-10 |
2020-11-24 |
Ampio Pharmaceuticals Inc |
Degenerative arthropathy treatment
|
EA201490737A1
(en)
|
2011-10-28 |
2014-09-30 |
Ампио Фармасьютикалз, Инк. |
TREATMENT OF RHINITIS
|
SG10201705044YA
(en)
|
2012-12-19 |
2017-07-28 |
Ampio Pharmaceuticals Inc |
Method for treatment of diseases
|
CA2906864A1
(en)
|
2013-03-15 |
2014-09-18 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
US9956217B2
(en)
|
2014-08-18 |
2018-05-01 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
WO2016209969A1
(en)
|
2015-06-22 |
2016-12-29 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|